Fcγ receptor deficiency attenuates diabetic nephropathy

Journal of the American Society of Nephrology

Volumn 23, Issue 9, 2012, Pages 1518-1527

  Lopez Parra, Virginia ^a   Mallavia, Beñat ^a   Lopez Franco, Oscar ^a   Ortiz Muñoz, Guadalupe ^a   Oguiza, Ainhoa ^a   Recio, Carlota ^a   Blanco, Julia ^b   Nimmerjahn, Falk ^c   Egido, Jesus ^a   Gomez Guerrero, Carmen ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA SMOOTH MUSCLE ACTIN; APOLIPOPROTEIN E; COLLAGEN; COMPLEMENT COMPONENT C3; CREATININE; FC RECEPTOR; GLUCOSE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN M; MESSENGER RNA; STREPTOZOCIN;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL EXPANSION; CELL INFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; IMMUNE COMPLEX DEPOSITION; IMMUNOGLOBULIN PRODUCTION; INFLAMMATORY CELL; KIDNEY FIBROSIS; KIDNEY HYPERTROPHY; MALE; MESANGIUM; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SUBUNIT; STREPTOZOCIN DIABETES;

EID: 84865965995     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011080822     Document Type: Article

References (49)

1. Nathan DM: Long-term complications of diabetes mellitus. N Engl J Med 328: 1676-1685, 1993
2. De Cosmo S, Bacci S, Piras GP, Cignarelli M, Placentino G, Margaglione M, Colaizzo D, Di Minno G, Giorgino R, Liuzzi A, Viberti GC: High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria. Diabetologia 40: 1191-1196, 1997 (Pubitemid 27421891)
3. Nilsson J, Bengtsson E, Fredrikson GN, Björkbacka H: Inflammation and immunity in diabetic vascular complications.Curr Opin Lipidol 19: 519-524, 2008
4. Navarro-González JF, Mora-Fernández C: The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 19: 433-442, 2008
5. Wen M, Segerer S, Dantas M, Brown PA, Hudkins KL, Goodpaster T, Kirk E, LeBoeuf RC, Alpers CE: Renal injury in apolipoprotein Edeficient mice. Lab Invest 82: 999-1006, 2002
6. Lassila M, Seah KK, Allen TJ, Thallas V, Thomas MC, Candido R, Burns WC, Forbes JM, Calkin AC, Cooper ME, Jandeleit-Dahm KA: Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: Role of advanced glycation end products. J Am Soc Nephrol 15: 2125-2138, 2004 (Pubitemid 39031351)
7. Hirano T: Lipoprotein abnormalities in diabetic nephropathy. Kidney Int Suppl 71: S22-S24, 1999
8. Lopes-Virella MF, Virella G: Clinical significance of the humoral immune response to modified LDL. Clin Immunol 134: 55-65, 2010
9. Ait-Oufella H, Herbin O, Bouaziz JD, Binder CJ, Uyttenhove C, Laurans L, Taleb S, Van Vré E, Esposito B, Vilar J, Sirvent J, Van Snick J, Tedgui A, Tedder TF, Mallat Z: B cell depletion reduces the development of atherosclerosis in mice. J Exp Med 207: 1579-1587, 2010
10. Nicoloff G, Baydanoff S, Petrova C, Christova P: Antibodies to advanced glycation end products in children with diabetes mellitus. Vascul Pharmacol 39: 39-45, 2002 (Pubitemid 36398244)
11. Atchley DH, Lopes-Virella MF, Zheng D, Kenny D, Virella G: Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy. Diabetologia 45: 1562-1571, 2002 (Pubitemid 35352050)
12. Lopes-Virella MF, McHenry MB, Lipsitz S, Yim E, Wilson PF, Lackland DT, Lyons T, Jenkins AJ, Virella G; DCCT/EDIC Research Group: Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes. Atherosclerosis 190: 359-369, 2007 (Pubitemid 46074026)
13. Takai T: Fc receptors and their role in immune regulation and autoimmunity. J Clin Immunol 25: 1-18, 2005
14. Nimmerjahn F, Ravetch JV: Fcgamma receptors: old friends and new family members. Immunity 24: 19-28, 2006 (Pubitemid 43077197)
15. Gómez-Guerrero C, López-Armada MJ, González E, Egido J: Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation. J Immunol 153: 5247-5255, 1994 (Pubitemid 24983927)
16. Radeke HH, Janssen-Graalfs I, Sowa EN, Chouchakova N, Skokowa J, Löscher F, Schmidt RE, Heeringa P, Gessner JE: Opposite regulation of type II and III receptors for immunoglobulin G in mouse glomerular mesangial cells and in the induction of anti-glomerular basement membrane (GBM) nephritis. J Biol Chem 277: 27535-27544, 2002 (Pubitemid 34951774)
17. Gómez-Guerrero C, López-Franco O, Suzuki Y, Sanjuán G, Hernández-Vargas P, Blanco J, Egido J: Nitric oxide production in renal cells by immune complexes: Role of kinases and nuclear factor-kappaB. Kidney Int 62: 2022-2034, 2002 (Pubitemid 35366156)
18. Calverley DC, Baldermann LV, Heldt ML, Kinney GL, Hokanson JE: Increased platelet Fc receptor expression in diabetes is limited to those with type 2 disease and low LDL cholesterol levels. Atherosclerosis 185: 173-176, 2006 (Pubitemid 43117565)
19. Suzuki Y, Shirato I, Okumura K, Ravetch JV, Takai T, Tomino Y, Ra C: Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis. Kidney Int 54: 1166-1174, 1998 (Pubitemid 28449903)
20. Inoue Y, Kaifu T, Sugahara-Tobinai A, Nakamura A, Miyazaki J, Takai T: Activating Fc gamma receptors participate in the development of autoimmune diabetes in NOD mice. J Immunol 179: 764-774, 2007
21. Hernández-Vargas P, Ortiz-Muñoz G, López-Franco O, Suzuki Y, Gallego-Delgado J, Sanjuán G, Lázaro A, López-Parra V, Ortega L, Egido J, Gómez-Guerrero C: Fcgamma receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice. Circ Res 99: 1188-1196, 2006
22. Alizadeh BZ, Valdigem G, Coenen MJ, Zhernakova A, Franke B, Monsuur A, van Riel PL, Barrera P, Radstake TR, Roep BO, Wijmenga C, Koeleman BP: Association analysis of functional variants of the FcgRIIa and FcgRIIIa genes with type 1 diabetes, celiac disease and rheumatoid arthritis. Hum Mol Genet 16: 2552-2559, 2007 (Pubitemid 47617722)
23. Raaz D, Herrmann M, Ekici AB, Klinghammer L, Lausen B, Voll RE, Leusen JH, van de Winkel JG, Daniel WG, Reis A, Garlichs CD: FcgammaRIIa genotype is associated with acute coronary syndromes as first manifestation of coronary artery disease. Atherosclerosis 205: 512-516, 2009
24. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N: Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci U S A 89: 4471-4475, 1992
25. Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV: FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 76: 519-529, 1994 (Pubitemid 24064172)
26. Park SY, Ueda S, Ohno H, Hamano Y, Tanaka M, Shiratori T, Yamazaki T, Arase H, Arase N, Karasawa A, Sato S, Ledermann B, Kondo Y, Okumura K, Ra C, Saito T: Resistance of Fc receptor- deficient mice to fatal glomerulonephritis. J Clin Invest 102: 1229-1238, 1998 (Pubitemid 28436283)
27. Tesch GH, Allen TJ: Rodentmodels of streptozotocin-induced diabetic nephropathy. Nephrology (Carlton) 12: 261-266, 2007
28. Bonventre JV: Kidney Injury Molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury. Scand J Clin Lab Invest Suppl 241: 78-83, 2008
29. Spencer MW, Mühlfeld AS, Segerer S, Hudkins KL, Kirk E, LeBoeuf RC, Alpers CE: Hyperglycemia and hyperlipidemia act synergistically to induce renal disease in LDL receptor-deficient BALB mice. Am J Nephrol 24: 20-31, 2004 (Pubitemid 38250483)
30. Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC, Rollin BJ, Tesch GH: Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int 69: 73-80, 2006 (Pubitemid 43117741)
31. Liu Y: Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15: 1-12, 2004
32. DiMario U, Borsey DQ, Contreas G, Prowse CV, Clarke BF, Andreani D: The relationship of soluble immune complexes, insulin antibodies and insulin-anti-insulin complexes to platelet and coagulation factors in type 1 diabetic patients with and without proliferative retinopathy. Clin Exp Immunol 65: 57-65, 1986 (Pubitemid 16092886)
33. Tomino Y, Wang LN, Fukui M, Yaguchi Y, Koide H: Glomerular nonenzymatic glycosylation and lipid peroxide are increased in the early phase of streptozotocin-induced diabetic rats prior to major histopathologic alterations. Nephron 59: 632-636, 1991
34. Xiao X, Ma B, Dong B, Zhao P, Tai N, Chen L, Wong FS, Wen L: Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice. J Autoimmun 32: 85-93, 2009
35. Lim AK, Ma FY, Nikolic-Paterson DJ, Kitching AR, Thomas MC, Tesch GH: Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury. Diabetologia 53: 1772-1782, 2010
36. Cavallo T, Pinto JA, Rajaraman S: Immune complex disease complicating diabetic glomerulosclerosis. Am J Nephrol 4: 347-354, 1984 (Pubitemid 15189807)
37. Alsaad KO, Herzenberg AM: Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: An update. J Clin Pathol 60: 18-26, 2007 (Pubitemid 46142667)
38. Abdelsamie SA, Li Y, Huang Y, Lee MH, Klein RL, Virella G, Lopes-Virella MF: Oxidized LDL immune complexes stimulate collagen IV production in mesangial cells via Fc gamma receptors I and III. Clin Immunol 139: 258-266, 2011
39. Forbes JM, Coughlan MT, Cooper ME: Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57: 1446-1454, 2008
40. Kitada M, Koya D, Sugimoto T, Isono M, Araki S, Kashiwagi A, Haneda M: Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy. Diabetes 52: 2603-2614, 2003 (Pubitemid 37210551)
41. Li JM, Shah AM: ROS generation by nonphagocytic NADPH oxidase: Potential relevance in diabetic nephropathy. J Am Soc Nephrol 14 [Suppl 3]: S221-S226, 2003
42. Satriano J, Schlondorff D: Activation and attenuation of transcription factor NF-kB inmouse glomerular mesangial cells in response to tumor necrosis factor-alpha, immunoglobulin G, and adenosine 3′:5′-cyclic monophosphate. Evidence for involvement of reactive oxygen species. J Clin Invest 94: 1629-1636, 1994
43. Suzuki Y, Gómez-Guerrero C, Shirato I, López-Franco O, Gallego-Delgado J, Sanjuán G, Lázaro A, Hernández-Vargas P, Okumura K, Tomino Y, Ra C, Egido J: Pre-existing glomerular immune complexes induce polymorphonuclear cell recruitment through an Fc receptordependent respiratory burst: Potential role in the perpetuation of immune nephritis. J Immunol 170: 3243-3253, 2003 (Pubitemid 36302202)
44. Liu Y, Masuda E, Blank MC, Kirou KA, Gao X, Park MS, Pricop L: Cytokine-mediated regulation of activating and inhibitory Fc gamma receptors in human monocytes. J Leukoc Biol 77: 767-776, 2005 (Pubitemid 40628757)
45. Ichii O, Konno A, Sasaki N, Endoh D, Hashimoto Y, Kon Y: Altered balance of inhibitory and active Fc gamma receptors in murine autoimmune glomerulonephritis. Kidney Int 74: 339-347, 2008 (Pubitemid 352001246)
46. Yamamoto M, Kobayashi K, Ishikawa Y, Nakata K, Funada Y, Kotani Y, Masuda A, Takai T, Azuma T, Yoshida M, Nishimura Y: The inhibitory effects of intravenous administration of rabbit immunoglobulin G on airway inflammation are dependent upon Fcg receptor IIb on CD11c(+)dendritic cells in a murine model. Clin Exp Immunol 162: 315-324, 2010
47. Pavlovic S, Zdravkovic N, Dimitrov JD, Djukic A, Arsenijevic N, Vassilev TL, Lukic ML: Intravenous immunoglobulins exposed to heme (heme IVIG) are more efficient than IVIG in attenuating autoimmune diabetes. Clin Immunol 138: 162-171, 2011
48. Gómez-Guerrero C, López-Franco O, Sanjuán G, Hernández-Vargas P, Suzuki Y, Ortiz-Muñoz G, Blanco J, Egido J: Suppressors of cytokine signaling regulate Fc receptor signaling and cell activation during immune renal injury. J Immunol 172: 6969-6977, 2004 (Pubitemid 38669137)
49. López-Franco O, Hernández-Vargas P, Ortiz-Muñoz G, Sanjuán G, Suzuki Y, Ortega L, Blanco J, Egido J, Gómez-Guerrero C: Parthenolide modulates the NF-kappaB-mediated inflammatory responses in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 26: 1864-1870, 2006